Search

Chameli Das

Examiner (ID: 7327, Phone: (571)272-3696 , Office: P/2197 )

Most Active Art Unit
2197
Art Unit(s)
2197, 2196, 2762, 2122, 2192
Total Applications
1155
Issued Applications
1034
Pending Applications
35
Abandoned Applications
96

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7801160 [patent_doc_number] => 08129432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor' [patent_app_type] => utility [patent_app_number] => 12/526311 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 21 [patent_no_of_words] => 7552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129432.pdf [firstpage_image] =>[orig_patent_app_number] => 12526311 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/526311
Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor Feb 14, 2008 Issued
Array ( [id] => 4718648 [patent_doc_number] => 20080241170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells' [patent_app_type] => utility [patent_app_number] => 12/024897 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17873 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241170.pdf [firstpage_image] =>[orig_patent_app_number] => 12024897 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/024897
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Jan 31, 2008 Issued
Array ( [id] => 4532509 [patent_doc_number] => 07871784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins' [patent_app_type] => utility [patent_app_number] => 12/024715 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 28830 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871784.pdf [firstpage_image] =>[orig_patent_app_number] => 12024715 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/024715
Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins Jan 31, 2008 Issued
Array ( [id] => 6143127 [patent_doc_number] => 20110129845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'METHOD OF DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 12/523506 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12253 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129845.pdf [firstpage_image] =>[orig_patent_app_number] => 12523506 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523506
METHOD OF DIAGNOSIS Jan 24, 2008 Abandoned
Array ( [id] => 6577713 [patent_doc_number] => 20100047299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE' [patent_app_type] => utility [patent_app_number] => 12/524229 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 11801 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047299.pdf [firstpage_image] =>[orig_patent_app_number] => 12524229 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524229
USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE Jan 23, 2008 Abandoned
Array ( [id] => 5491036 [patent_doc_number] => 20090292107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/018582 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 30258 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20090292107.pdf [firstpage_image] =>[orig_patent_app_number] => 12018582 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/018582
COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECT Jan 22, 2008 Abandoned
Array ( [id] => 4813853 [patent_doc_number] => 20080194484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'TML polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/009230 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18568 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194484.pdf [firstpage_image] =>[orig_patent_app_number] => 12009230 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/009230
TML polynucleotides Jan 15, 2008 Abandoned
Array ( [id] => 8749469 [patent_doc_number] => 08415302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Surgical applications for BMP binding protein' [patent_app_type] => utility [patent_app_number] => 12/448497 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 10852 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12448497 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/448497
Surgical applications for BMP binding protein Dec 25, 2007 Issued
Array ( [id] => 8176219 [patent_doc_number] => 08178099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Methods of altering bone growth by administration of sost or wise antagonist or agonist' [patent_app_type] => utility [patent_app_number] => 11/962522 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9705 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178099.pdf [firstpage_image] =>[orig_patent_app_number] => 11962522 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/962522
Methods of altering bone growth by administration of sost or wise antagonist or agonist Dec 20, 2007 Issued
Array ( [id] => 5271002 [patent_doc_number] => 20090074778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Connective Tissue Growth Factor (CTGF-3)' [patent_app_type] => utility [patent_app_number] => 11/962282 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074778.pdf [firstpage_image] =>[orig_patent_app_number] => 11962282 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/962282
Connective tissue growth factor (CTGF-3) Dec 20, 2007 Issued
Array ( [id] => 6480684 [patent_doc_number] => 20100092558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Method for Producing a Product Having a Polymer Matrix, Implants Made Thereof and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/520527 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4592 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092558.pdf [firstpage_image] =>[orig_patent_app_number] => 12520527 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520527
Method for producing a product having a polymer matrix, implants made thereof and use thereof Dec 18, 2007 Issued
Array ( [id] => 5992955 [patent_doc_number] => 20110014608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/520515 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17800 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014608.pdf [firstpage_image] =>[orig_patent_app_number] => 12520515 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520515
Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases Dec 18, 2007 Issued
Array ( [id] => 6231397 [patent_doc_number] => 20100184659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents' [patent_app_type] => utility [patent_app_number] => 12/516922 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11539 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184659.pdf [firstpage_image] =>[orig_patent_app_number] => 12516922 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/516922
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents Dec 18, 2007 Abandoned
Array ( [id] => 6513920 [patent_doc_number] => 20100216704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELS' [patent_app_type] => utility [patent_app_number] => 12/516961 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13358 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216704.pdf [firstpage_image] =>[orig_patent_app_number] => 12516961 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/516961
Genes and proteins that home to developing microvessels Nov 29, 2007 Issued
Array ( [id] => 8214601 [patent_doc_number] => 08193312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Bone morphogenic protein binding peptide' [patent_app_type] => utility [patent_app_number] => 11/985745 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 7448 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193312.pdf [firstpage_image] =>[orig_patent_app_number] => 11985745 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/985745
Bone morphogenic protein binding peptide Nov 15, 2007 Issued
Array ( [id] => 4682282 [patent_doc_number] => 20080248508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials' [patent_app_type] => utility [patent_app_number] => 11/985057 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9746 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248508.pdf [firstpage_image] =>[orig_patent_app_number] => 11985057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/985057
Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials Nov 12, 2007 Abandoned
Array ( [id] => 6645912 [patent_doc_number] => 20100313281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'VARIANTS AND METHODS OF USING TRANSFORMING GROWTH FACTOR BETA-9' [patent_app_type] => utility [patent_app_number] => 12/514143 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20891 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20100313281.pdf [firstpage_image] =>[orig_patent_app_number] => 12514143 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/514143
VARIANTS AND METHODS OF USING TRANSFORMING GROWTH FACTOR BETA-9 Nov 7, 2007 Abandoned
Array ( [id] => 4833363 [patent_doc_number] => 20080131910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use' [patent_app_type] => utility [patent_app_number] => 11/980023 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12358 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131910.pdf [firstpage_image] =>[orig_patent_app_number] => 11980023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/980023
Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use Oct 29, 2007 Abandoned
Array ( [id] => 5398278 [patent_doc_number] => 20090318341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Methods of using OSK1 peptide analogs' [patent_app_type] => utility [patent_app_number] => 11/978119 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 128 [patent_no_of_words] => 109394 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318341.pdf [firstpage_image] =>[orig_patent_app_number] => 11978119 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/978119
Methods of using OSK1 peptide analogs Oct 24, 2007 Issued
Array ( [id] => 5316430 [patent_doc_number] => 20090281028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'OSK1 peptide analogs and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/978110 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 128 [patent_no_of_words] => 109417 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281028.pdf [firstpage_image] =>[orig_patent_app_number] => 11978110 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/978110
OSK1 peptide analogs and pharmaceutical compositions Oct 24, 2007 Issued
Menu